FARMAPRESS
ActiveSummary
FARMAPRESS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,000 and a net result of €15,235. Equity has been growing by about 2.7% per year since 2018. Its solvency ranks better than 21% of 324 sector peers (NACE 58, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Official details
Source: KBO- Status
- Active since 16-10-2009 Normal situation
- Registered office
- 39 active companies are registered at this address 1 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Publishing activities NACE 58130and 1 other
- Establishment unit
- 2.181.997.380 1380 Lasne, since 16-10-2009
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Board and ownership
- DECALLONNE Valérie Sophie CarolDirector · since 20-12-2023
- J.M.V.D.Director · since 17-01-2025 · permanent representative De Witte Jean-Michel
- J.M.V.D.100%· score 912025 annual accounts of J.M.V.D.
- VENTURES MEDIA· score 66act of 28-12-2023
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.4%
- Gross margin
- €21,962
- ▲ 82.6%
- Turnover
- ≈ €150,000
- estimated
- Profit
- €15,235
- ▲ 218×
- Equity
- €30,000
- ▼ 52.3%
- Total assets
- €302,187
- ▲ 18.2%
Score breakdownraises risk1 change of registered office in 24 months1 of the last 3 accounts latelowers riskSector: Publishing activities (NACE 58)Liquidity: current ratio 1.11, cash €103,388Show the evidence
Checked score
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 58, micro). It does better than 26% of them on solvency, 28% on liquidity, 38% on profitability and 14% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 286 days after the deadline. In the sector (NACE 58), the median for financial year 2024 was 7 days before the deadline, and 37% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 8 profitable years in a rowprofit 2025: €15,235 8 years View
Recent changes
- · Gazette deed Registered office moved from Lasne to Mont-Saint-GuibertResignation: De Wasseige Bernard (director) · Appointment: J.M.V.D SRL (director) · Permanent representative: De Witte Jean-Michel
- · Gazette deed Change of role: de WASSEIGE Bernard Marie Armand Laurent, from manager to directorAppointment: DECALLONNE Valérie Sophie Carol (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as FARMAPRESS: publishing activities (NACE 58130). They are comparable in size and age: total assets between €170,000 and €682,000, founded between 2007 and 2014.
| Company | Total assets | Gross margin |
|---|---|---|
| FARMAPRESS Mont-Saint-Guibert | €302,187 | €21,962 |
| Pro Pharma Communications International Mol | €325,912 | €31,280 |
| COURRIER INTERNATIONAL EBL Etterbeek | €342,148 | €10,268 |
| EDITIONS MAGLIFE Lasne | €190,005 | €7,238 |
| INSIDE EDITIONS Elsene | €170,418 | €40,973 |
| Targa Media Destelbergen | €305,507 | €53,600 |
| WIEPER Zemst | €681,663 | €40,197 |
Key facts about FARMAPRESS
- What is the company number of FARMAPRESS?
- The company number of FARMAPRESS is 0819.882.503. The VAT number is the same number with BE in front: BE 0819.882.503.
- Where is FARMAPRESS based?
- The registered office is at Rue du Fond Cattelain 1, 1435 Mont-Saint-Guibert.Company details
- What does FARMAPRESS do?
- According to the KBO register, the main activity is publishing activities (NACE 58130).
- What is the legal form of FARMAPRESS?
- The legal form of FARMAPRESS is Private limited company (BV).
- When was FARMAPRESS founded?
- FARMAPRESS was founded on 16-10-2009.
- Is FARMAPRESS still active?
- Yes, FARMAPRESS is an active enterprise in the KBO register.
- What is the turnover of FARMAPRESS?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €21,962 and 2,698 comparable companies of the same size. It probably lies between €62,000 and €370,000. It is a rough estimate.Financials
- Is FARMAPRESS profitable?
- In financial year 2025, FARMAPRESS made a profit of €15,235.
- Where can I find the annual accounts of FARMAPRESS?
- FARMAPRESS filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FARMAPRESS due?
- FARMAPRESS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.